ExpertiseUpdated on 15 May 2026
Accelerating Animal Health R&D through Biological Intelligence
About
At BioLizard, we bridge the gap between complex biological data and strategic R&D decision-making. We support animal health companies by providing biology-driven data science and end-to-end bioinformatics solutions.
Our Core Expertise Includes:
-
Biomarker discovery and validation: through single and multi-omics analysis (genomics, transcriptomics, proteomics, metabolomics), we identify and rank biomarkers for early research, translational studies, and clinical validation.
-
Drug target discovery and MoA: single-cell and spatial transcriptomics let us map how interventions influence pathways and tissue environments, helping you better understand disease biology, identify novel targets, and profile therapeutic efficacy.
-
Clinical-grade scientific workflows: we build robust, scalable, and FAIR-compliant pipelines that ensure your data remains traceable and reproducible from preclinical R&D to Phase 3.
-
Data engineering and software development: using our Bio|Verse® platform, we develop custom dashboards and cloud-based architectures that allow your internal teams to explore their data without needing to be coding experts.
If you are looking to optimize your R&D pipeline, find new indications for existing compounds via drug repurposing, or build a scalable data infrastructure, we act as an extension of your own scientific team and bring the necessary data expertise.
Field
- Clinical & Veterinary Research
- Translational & Applied Research
- Biotechnology & Life Sciences
- Digital Health & Data Science
- AI & Predictive Analytics
- Diagnostics Development
- Agritech & Precision Livestock
- Epidemiology & Infectious Disease
Organisation
Belgium
Similar opportunities
Expertise
Nanobody engineering and translational biologics development
Nicolás Galmarini
CEO & Co-founder at NanoVet Biotech
Pamplona, Spain
Service
GMP manufacturing of cell-based products
- Research
- Consulting
- Development
- Manufacturing
- Regulatory Support
- Pharmaceutical R&D
- Testing & Validation
- Veterinary & Animal Health
- Biotechnology & Life Sciences
Endre Kiss-Toth
Founder, CEO at StemcellX Limited
Sheffield, United Kingdom
Investment
Accelerate preclinical and clinical development
Nicolás Galmarini
CEO & Co-founder at NanoVet Biotech
Pamplona, Spain